These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34314509)

  • 1. Mapping the miRNA-mRNA Interactome in Human Hepatocytes and Identification of Functional mirSNPs in Pharmacogenes.
    Powell NR; Zhao H; Ipe J; Liu Y; Skaar TC
    Clin Pharmacol Ther; 2021 Oct; 110(4):1106-1118. PubMed ID: 34314509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PASSPORT-seq: A Novel High-Throughput Bioassay to Functionally Test Polymorphisms in Micro-RNA Target Sites.
    Ipe J; Collins KS; Hao Y; Gao H; Bhatia P; Gaedigk A; Liu Y; Skaar TC
    Front Genet; 2018; 9():219. PubMed ID: 29963077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA hsa-miR-25-3p suppresses the expression and drug induction of CYP2B6 in human hepatocytes.
    Jin Y; Yu D; Tolleson WH; Knox B; Wang Y; Chen S; Ren Z; Deng H; Guo Y; Ning B
    Biochem Pharmacol; 2016 Aug; 113():88-96. PubMed ID: 27311985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a miRSNP Regulatory Axis in Abdominal Aortic Aneurysm by a Network and Pathway-Based Integrative Analysis.
    Liu S; Liao Y; Liu C; Zhou H; Chen G; Lu W; Huang Z
    Oxid Med Cell Longev; 2022; 2022():8776566. PubMed ID: 36275900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of miRSNPs associated with the risk of multiple myeloma.
    Macauda A; Calvetti D; Maccari G; Hemminki K; Försti A; Goldschmidt H; Weinhold N; Houlston R; Andersen V; Vogel U; Buda G; Varkonyi J; Sureda A; Martinez Lopez J; Watek M; Butrym A; Sarasquete ME; Dudziński M; Jurczyszyn A; Druzd-Sitek A; Kruszewski M; Subocz E; Petrini M; Iskierka-Jażdżewska E; Raźny M; Szombath G; Marques H; Zawirska D; Chraniuk D; Halka J; Hove Jacobsen SE; Mazur G; García Sanz R; Dumontet C; Moreno V; Stępień A; Beider K; Pelosini M; Manuel Reis R; Krawczyk-Kulis M; Rymko M; Avet-Loiseau H; Lesueur F; Grząśko N; Ostrovsky O; Jamroziak K; Vangsted AJ; Jerez A; Tomczak W; Zaucha JM; Kadar K; Sainz J; Nagler A; Landi S; Gemignani F; Canzian F
    Int J Cancer; 2017 Feb; 140(3):526-534. PubMed ID: 27718532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
    Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
    Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence-based analysis of 5'UTR and coding regions of CASP3 in terms of miRSNPs and SNPs in targetting miRNAs.
    Ergun S; Oztuzcu S
    Comput Biol Chem; 2016 Jun; 62():70-4. PubMed ID: 27107179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative Analysis Identifies Genetic Variants Associated With Autoimmune Diseases Affecting Putative MicroRNA Binding Sites.
    de Almeida RC; Chagas VS; Castro MAA; Petzl-Erler ML
    Front Genet; 2018; 9():139. PubMed ID: 29755505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variations in microRNA-binding sites of solute carrier transporter genes as predictors of clinical outcome in colorectal cancer.
    Bendova P; Pardini B; Susova S; Rosendorf J; Levy M; Skrobanek P; Buchler T; Kral J; Liska V; Vodickova L; Landi S; Soucek P; Naccarati A; Vodicka P; Vymetalkova V
    Carcinogenesis; 2021 Apr; 42(3):378-394. PubMed ID: 33319241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer.
    Stegeman S; Amankwah E; Klein K; O'Mara TA; Kim D; Lin HY; Permuth-Wey J; Sellers TA; Srinivasan S; Eeles R; Easton D; Kote-Jarai Z; Amin Al Olama A; Benlloch S; Muir K; Giles GG; Wiklund F; Gronberg H; Haiman CA; Schleutker J; Nordestgaard BG; Travis RC; Neal D; Pharoah P; Khaw KT; Stanford JL; Blot WJ; Thibodeau S; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Kaneva R; Teixeira MR; ; ; Spurdle AB; Clements JA; Park JY; Batra J
    Cancer Discov; 2015 Apr; 5(4):368-79. PubMed ID: 25691096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel epigenetic mechanism unravels hsa-miR-148a-3p-mediated CYP2B6 downregulation in alcoholic hepatitis disease.
    Luo J; Xie M; Hou Y; Ma W; Jin Y; Chen J; Li C; Zhao K; Chen N; Xu L; Ji Y; Zhang Q; Zheng Y; Yu D
    Biochem Pharmacol; 2021 Jun; 188():114582. PubMed ID: 33895159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
    Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
    Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic evaluation of microRNAs in regulating human hepatic CYP2E1.
    Wang Y; Yu D; Tolleson WH; Yu LR; Green B; Zeng L; Chen Y; Chen S; Ren Z; Guo L; Tong W; Guan H; Ning B
    Biochem Pharmacol; 2017 Aug; 138():174-184. PubMed ID: 28438567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide integrated analysis of miRNA and mRNA expression profiles to identify differentially expressed miR-22-5p and miR-27b-5p in response to classical swine fever vaccine virus.
    Sailo L; Kumar A; Sah V; Chaudhary R; Upmanyu V; Tiwari AK; Kumar A; Pandey A; Saxena S; Singh A; Wani SA; Gandham RK; Rai A; Mishra BP; Singh RK
    Funct Integr Genomics; 2019 Nov; 19(6):901-918. PubMed ID: 31134483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of miRNAs that regulate human CYP2B6 expression.
    Nakano M; Iwakami C; Fukami T; Nakajima M
    Drug Metab Pharmacokinet; 2021 Jun; 38():100388. PubMed ID: 33872945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation.
    Zeng L; Chen Y; Wang Y; Yu LR; Knox B; Chen J; Shi T; Chen S; Ren Z; Guo L; Wu Y; Liu D; Huang K; Tong W; Yu D; Ning B
    Biochem Pharmacol; 2017 Sep; 140():139-149. PubMed ID: 28552654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyrimidine dehydrogenase (DPD) expression is negatively regulated by certain microRNAs in human lung tissues.
    Hirota T; Date Y; Nishibatake Y; Takane H; Fukuoka Y; Taniguchi Y; Burioka N; Shimizu E; Nakamura H; Otsubo K; Ieiri I
    Lung Cancer; 2012 Jul; 77(1):16-23. PubMed ID: 22306127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.
    Dzikiewicz-Krawczyk A; Macieja A; Mały E; Januszkiewicz-Lewandowska D; Mosor M; Fichna M; Strauss E; Nowak J
    J Hematol Oncol; 2014 Jun; 7():43. PubMed ID: 24886876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNAs miR-27a and miR-27b directly regulate liver dihydropyrimidine dehydrogenase expression through two conserved binding sites.
    Offer SM; Butterfield GL; Jerde CR; Fossum CC; Wegner NJ; Diasio RB
    Mol Cancer Ther; 2014 Mar; 13(3):742-51. PubMed ID: 24401318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The landscape of miRNA-mRNA regulatory network and cellular sources in inflammatory bowel diseases: insights from text mining and single cell RNA sequencing analysis.
    Li Y; Wang Y; Chen S; Liu L
    Front Immunol; 2024; 15():1454532. PubMed ID: 39238649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.